Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TYR | P14679 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL60651 | 0.87 | ALDH1A1 (0.40) | ALDH1A1CA2POLBTYRSMN1; SMN2 | |
| SCHEMBL4648563 | 0.82 | KDM4E (0.33) | ALDH1A1POLBSMN1; SMN2 | |
| SCHEMBL6013954 | 0.80 | ALDH1A1 (0.36) | ALDH1A1CA2POLBTYRSMN1; SMN2 | |
| SCHEMBL15067408 | 0.78 | — | — | |
| SCHEMBL27854953 | 0.76 | ALDH1A1 (0.43) | ALDH1A1CA2POLBTYRSMN1; SMN2 | |
| SCHEMBL8168542 | 0.76 | ALDH1A1 (0.33) | ALDH1A1CA2POLBTYRSMN1; SMN2 | |
| SCHEMBL3121979 | 0.75 | GABRA1 (0.39) | ALDH1A1POLB | |
| SCHEMBL9338679 | 0.75 | ALDH1A1 (0.32) | ALDH1A1CA2POLBTYRSMN1; SMN2 | |
| SCHEMBL1304783 | 0.75 | ALDH1A1 (0.32) | ALDH1A1CA2POLBTYRSMN1; SMN2 | |
| SCHEMBL3823195 | 0.73 | ALDH1A1 (0.34) | ALDH1A1CA2POLBTYRSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1312598-B1 | Process for producing aldehyde | MITSUBISHI CHEM CORP (JP) | 2005-02-16 | — | — | EP | disclosed |
| EP-1008581-B1 | Process for producing aldehyde | MITSUBISHI CHEM CORP (JP) | 2004-04-21 | — | — | EP | disclosed |
| US-6610891-B1 | Reduces degradation or decomposition of catalyst | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-08-26 | — | — | US | disclosed |
| US-6583324-B2 | By hydroformylation with rhodium complex catalyst containing an organic phosphite ligand; preventing catalyst poisoning by having the aldehyde remain in the catalyst solution in the separation step | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-06-24 | — | — | US | disclosed |
| EP-1312598-A1 | Process for producing aldehyde | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-05-21 | — | — | EP | disclosed |
| US-20020049355-A1 | Process for producing aldehyde | MITSUBISHI CHEMICAL CORPORATION (JP) | 2002-04-25 | — | — | US | disclosed |
| US-6291717-B1 | REACTING OLEFINIC COMPOUND WITH CARBON MONOXIDE AND HYDROGEN IN THE PRESENCE OF A RHODIUM COMPLEX CATALYST COMPRISING RHODIUM AND ORGANIC PHOSPHITE IN REACTION ZONE; SEPARATING CATALYST AND ALDEHYDE; RECYCLING CATALYST SOLUTION | MITSUBISHI CHEMICAL CORPORATION (JP) | 2001-09-18 | — | — | US | disclosed |
| US-6265620-B1 | REACTING OLEFINIC COMPOUND WITH CARBON MONOXIDE AND HYDROGEN IN PRESENCE OF CATALYST CONTAINING METAL OF GROUP 8 TO 10 AND TRIVALENT ORANIC PHOSPHORUS COMPOUND TO PRODUCE ALDEHYDE | MITSUBISHI CHEMICAL CORPORATION (JP) | 2001-07-24 | — | — | US | disclosed |
| EP-1008581-A1 | Process for producing aldehyde | MITSUBISHI CHEMICAL CORPORATION (JP) | 2000-06-14 | — | — | EP | disclosed |
| US-5962744-A | USING CATALYST COMPLEX CONTAINING TRANSITION METAL AND PHOSPHITE LIGAND | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 1999-10-05 | — | — | US | disclosed |
| US-5910600-A | Bisphosphite compound, process for its production and hydroformylation process employing the bisphosphite compound | MITSUBISHI CHEMICAL CORPORATION (JP) | 1999-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020049355-A1 | Process for producing aldehyde | ALDH2, OGDH, HAO2 | ALDH1A1 16/4885CA2 195/4885POLB 705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.